Main > OPHTHALMOLOGY > USA. A. Glaucoma>Treat.> ** > >Combi. Compound Therapy>

---

>Combi. Compound Therapy>'s subsections
(*) EU CE Mark Date: 2021. 01.11
(*) UK Approval Date: 2021. 04.19.
(*) USA Approval Date: 2019. 03.12.
>Rho Kinase Inh.+Prostaglandin>
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 6
Patent>UpDate: 2021. 03.09.
Prostaglandin Analogue: Latanoprost
Rho Kinase Inh.: Netarsudil
TradeMark (EU)
TradeMark (USA)
TradeMark (USA) Web-Site

>Combi. Compound Therapy>'s products
This section has no products